Most of these conserved TFBSs involved in breast cancer (e.g., AP-1, NFκB, and STAT5), stem cells and embryonic development (e.g., OCT1, PAX6, GATA1), and therefore had the highest potential for regulating CD44 and for being involved in breast cancer. Here, NFKB1 is linked to breast carcinoma.